Europe — EMA

Olmesartan Medoxomil Ipca Laboratories Uk

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil Ipca Laboratories Uk, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to treat hypertension in adults.

Olmesartan Medoxomil

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

GNH USA supplies Olmesartan Medoxomil Ipca Laboratories Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan medoxomil is an antihypertensive agent that works within the renin‑angiotensin‑aldosterone system to lower blood pressure. - Hypertension: Helps lower systolic and diastolic blood pressure in adult patients. - Heart failure post‑myocardial infarction: Reduces cardiac workload and improves outcomes. - Diabetic nephropathy: Slows progression of kidney damage associated with type 2 diabetes.

What are the side effects of Olmesartan Medoxomil?

Olmesartan medoxomil may ...

What precautions apply to Olmesartan Medoxomil?

Precautions ...

What does Olmesartan Medoxomil interact with?

Interaction

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →